Bracco: all 66 studies
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07702292Phase 2
- Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceRecruitingNCT07569926Phase 4
- [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07432633Phase 1/2
- Lumason® Infusion vs. Bolus AdministrationsRecruitingNCT06400004Phase 3
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionRecruitingNCT05413850Phase 1/2
- Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical ProstatectomyCompletedNCT06604442Phase 4Results posted
- Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)CompletedNCT04410367Phase 2Results posted
- Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain MetastasesCompletedNCT04410133Phase 3Results posted
- Optimal Timing of BR55 CEUS of the OvariesTerminatedNCT04248153Phase 2Results posted
- Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer RecurrenceCompletedNCT04186845Phase 3Results posted
- Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.CompletedNCT04186819Phase 3Results posted
- Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate CancerCompletedNCT03995888Phase 1Results posted
- Thyroid Function of Pediatric Subjects Following Isovue® AdministrationTerminatedNCT03779906Phase 4Results posted
- BR55 in Characterization of Ovarian LesionsTerminatedNCT03493464Phase 2Results posted
- Transabdominal Ultrasound With BR55 for Characterization of Pancreatic LesionsTerminatedNCT03486327Phase 2Results posted
- 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer TreatmentCompletedNCT02680041Phase 3Results posted
- Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcerCompletedNCT02578940Phase 3Results posted
- Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142CompletedNCT02552238Phase 3Results posted
- Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141CompletedNCT02522481Phase 3Results posted
- Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)CompletedNCT02443571Results posted
- Evaluation of Safety and Efficacy of Lumason in Pediatric EchocardiographyTerminatedNCT02282163Phase 3Results posted
- A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate CancerCompletedNCT02142608Phase 1/2Results posted
- Crossover Comparison of MultiHance and DotaremCompletedNCT02070380Phase 4Results posted
- Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the BrainCompletedNCT01613417Phase 4Results posted
- Safety of SonoVue on Pulmonary HemodynamicsCompletedNCT01306292Phase 2Results posted
- Kidney Damage in Patients With Normal eGFRCompletedNCT01137786Phase 4Results posted
- Kidney Damage In Patients With Severe Fall In eGFRTerminatedNCT01136915Phase 4Results posted
- Kidney Damage in Patients With Moderate Fall in eGFRCompletedNCT01136876Phase 4Results posted
- Isovue in Peripheral Digital Subtraction Angiography (DSA)CompletedNCT01075217Phase 4Results posted
- SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion CharacterizationCompletedNCT00829413Phase 3Results posted
- SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion CharacterizationCompletedNCT00788697Phase 3Results posted
- Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic PatientsTerminatedNCT00782639Phase 4Results posted
- Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSACompletedNCT00740207Phase 4Results posted
- Coronary MDCTA With Iopamidol Injection 370CompletedNCT00558792Phase 2Results posted
- Multihance at 3 Tesla (3T) in Brain TumorsCompletedNCT00395863Phase 4Results posted
- Safety and Efficacy of MultiHance in Pediatric PatientsTerminatedNCT00323310Phase 3Results posted
- A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate CancerTerminatedNCT06516510Early Phase 1
- Assessment of Superficial Femoral Artery Lesions With FFR From the ACIST Navvus® CatheterWithdrawnNCT05079906Not applicable
- Study With Oral Isovue in Abdominopelvic CTCompletedNCT04453059
- Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrsCompletedNCT03750188
- Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS PatientsCompletedNCT03147989
- Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With ControlCompletedNCT03108378
- A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA)CompletedNCT02596048Phase 4
- Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve MeasurementStatus unknownNCT02577484
- Retrospective Study of MRI in Pediatric PatientsCompletedNCT02291822
- Post-Market Registry of the ACIST CPM System and Navvus Catheter in Clinical PracticeCompletedNCT02060682
- Multidetector Computed Tomography (MDCT) Tailored ProtocolCompletedNCT01737333
- Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical SitesCompletedNCT01430975
- Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI ScanningCompletedNCT01424774
- Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral ArteriesCompletedNCT01260636Phase 3
- BR55 in Prostate Cancer: an Exploratory Clinical TrialCompletedNCT01253213Early Phase 1
- SonoVue Guided Prostate BiopsyTerminatedNCT00911027Phase 3
- Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the BrainCompletedNCT00907530Phase 4
- Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)CompletedNCT00773409
- Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney DiseaseCompletedNCT00600951
- Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney DiseaseCompletedNCT00600834
- Multihance Versus Magnevist in Breast MRICompletedNCT00486473Phase 3
- Follow-up Study to Previous CARE TrialCompletedNCT00479024
- Renal MRA Crossover Study Comparing Multihance to Another Contrast AgentCompletedNCT00415805Phase 3
- A Pharmacokinetics Study of MultiHance in Pediatric PatientsCompletedNCT00411931Phase 1
- Crossover Study With MultiHance vs a Comparator for Peripheral MRACompletedNCT00408083Phase 3
- Detection of Pulmonary Embolism With CECTCompletedNCT00351754Phase 4
- A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the BrainCompletedNCT00323102Phase 4
- Patients With Renal Impairment Undergoing CTCompletedNCT00292487Phase 4
- Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)CompletedNCT00289614Phase 4
- A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac AngiographyCompletedNCT00289029Phase 4